Literature DB >> 29459262

Soluble endoglin and hypercholesterolemia aggravate endothelial and vessel wall dysfunction in mouse aorta.

Barbora Vitverova1, Katerina Blazickova1, Iveta Najmanova1, Matej Vicen1, Radek Hyšpler2, Eva Dolezelova1, Ivana Nemeckova1, Jurjen Duintjer Tebbens3, Carmelo Bernabeu4, Miguel Pericacho5, Petr Nachtigal6.   

Abstract

BACKGROUND AND AIMS: Increased plasma levels of soluble endoglin (sEng) were detected in patients with endothelial dysfunction-related disorders and hypercholesterolemia. In this study, we hypothesized that high levels of sEng accompanied by mild hypercholesterolemia could aggravate endothelial and vessel wall dysfunction and affect endoglin/eNOS signaling in mouse aorta.
METHODS: Three-month-old female transgenic mice on CBAxC57BL/6J background, with high levels of sEng (Sol-Eng+high HFD), and their littermates with low levels of sEng (Sol-Eng+low HFD), were fed a high fat diet for six months. Plasma samples were used for biochemical, ELISA and Luminex analyses of total cholesterol, sEng and inflammatory markers. Functional parameters of aorta were assessed with wire myograph 620M. Western blot analyses of membrane endoglin/eNOS signaling and endothelial dysfunction/inflammation markers in aorta were performed.
RESULTS: Functional analysis of aorta showed impaired KCl induced vasoconstriction, endothelial-dependent relaxation after the administration of acetylcholine as well as endothelial-independent relaxation induced by sodium nitroprusside in the Sol-Eng+high HFD group compared to the Sol-Eng+low HFD group. Ach-induced vasodilation after administration of l-NAME was significantly higher in the Sol-Eng+high HFD group compared to the Sol-Eng+low HFD group. The expression of endoglin, p-eNOS/eNOS, pSmad2/3/Smad2/3 signaling pathway was significantly lower in the Sol-Eng+high HFD group compared to the Sol-Eng+low HFD group.
CONCLUSIONS: The results indicate that long-term hypercholesterolemia combined with high levels of sEng leads to the aggravation of endothelial and vessel wall dysfunction in aorta, with possible alterations of the membrane endoglin/eNOS signaling, suggesting that high levels of soluble endoglin might be considered as a risk factor of cardiovascular diseases.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Endothelial dysfunction; Mice; Soluble endoglin; Vascular reactivity; eNOS

Mesh:

Substances:

Year:  2018        PMID: 29459262     DOI: 10.1016/j.atherosclerosis.2018.02.008

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  11 in total

Review 1.  Membrane and soluble endoglin role in cardiovascular and metabolic disorders related to metabolic syndrome.

Authors:  Matej Vicen; Ivone Cristina Igreja Sá; Katarína Tripská; Barbora Vitverová; Iveta Najmanová; Samira Eissazadeh; Stanislav Micuda; Petr Nachtigal
Journal:  Cell Mol Life Sci       Date:  2020-11-13       Impact factor: 9.261

2.  Potential Role of Circulating Endoglin in Hypertension via the Upregulated Expression of BMP4.

Authors:  Eunate Gallardo-Vara; Luis Gamella-Pozuelo; Lucía Perez-Roque; José L Bartha; Irene Garcia-Palmero; J Ignacio Casal; José M López-Novoa; Miguel Pericacho; Carmelo Bernabeu
Journal:  Cells       Date:  2020-04-16       Impact factor: 6.600

3.  IL (Interleukin)-6 Contributes to Deep Vein Thrombosis and Is Negatively Regulated by miR-338-5p.

Authors:  Yunhong Zhang; Zhen Zhang; Ran Wei; Xiuming Miao; Shangwen Sun; Gang Liang; Chu Chu; Lin Zhao; Xiaoxiao Zhu; Qiang Guo; Bin Wang; Xia Li
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-12-19       Impact factor: 8.311

4.  Soluble Endoglin as a Potential Biomarker of Nonalcoholic Steatohepatitis (NASH) Development, Participating in Aggravation of NASH-Related Changes in Mouse Liver.

Authors:  Ivone Cristina Igreja Sá; Katarina Tripska; Milos Hroch; Radomir Hyspler; Alena Ticha; Hana Lastuvkova; Jolana Schreiberova; Eva Dolezelova; Samira Eissazadeh; Barbora Vitverova; Iveta Najmanova; Martina Vasinova; Miguel Pericacho; Stanislav Micuda; Petr Nachtigal
Journal:  Int J Mol Sci       Date:  2020-11-27       Impact factor: 5.923

5.  Monitoring of up to 15 years effects of lipoprotein apheresis on lipids, biomarkers of inflammation, and soluble endoglin in familial hypercholesterolemia patients.

Authors:  J Víšek; M Bláha; V Bláha; M Lášticová; M Lánska; C Andrýs; J Duintjer Tebbens; Ivone Cristina Igreja E Sá; K Tripská; M Vicen; I Najmanová; P Nachtigal
Journal:  Orphanet J Rare Dis       Date:  2021-02-27       Impact factor: 4.123

6.  Generation of a Soluble Form of Human Endoglin Fused to Green Fluorescent Protein.

Authors:  Lidia Ruiz-Llorente; M Cristina Vega; Francisco J Fernández; Carmen Langa; Nicholas W Morrell; Paul D Upton; Carmelo Bernabeu
Journal:  Int J Mol Sci       Date:  2021-10-19       Impact factor: 5.923

Review 7.  TGF-β superfamily co-receptors in cancer.

Authors:  John B Pawlak; Gerard C Blobe
Journal:  Dev Dyn       Date:  2021-04-09       Impact factor: 3.780

8.  Endoglin Protein Interactome Profiling Identifies TRIM21 and Galectin-3 as New Binding Partners.

Authors:  Eunate Gallardo-Vara; Lidia Ruiz-Llorente; Juan Casado-Vela; María J Ruiz-Rodríguez; Natalia López-Andrés; Asit K Pattnaik; Miguel Quintanilla; Carmelo Bernabeu
Journal:  Cells       Date:  2019-09-13       Impact factor: 6.600

9.  Role of soluble endoglin in BMP9 signaling.

Authors:  Aleksandra Lawera; Zhen Tong; Midory Thorikay; Rachael E Redgrave; Jie Cai; Maarten van Dinther; Nicholas W Morrell; Gijs B Afink; D Stephen Charnock-Jones; Helen M Arthur; Peter Ten Dijke; Wei Li
Journal:  Proc Natl Acad Sci U S A       Date:  2019-08-20       Impact factor: 11.205

10.  High Soluble Endoglin Levels Affect Aortic Vascular Function during Mice Aging.

Authors:  Iveta Nejmanová; Barbora Vitverová; Samira Eissazadeh; Katarina Tripská; Ivone Cristina Igreja Sa; Radomír Hyšpler; Ivana Němečkova; Miguel Pericacho; Petr Nachtigal
Journal:  J Cardiovasc Dev Dis       Date:  2021-12-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.